The World Health Organization published its latest Global Health Estimates on October 2, 2026, and the headline is genuinely good: the pandemic's damage to lifespan has essentially been repaired. Global life expectancy reached 73.3 years in 2023, close to the 73.4 recorded in 2019, across a data series tracking mortality and disease patterns from 2000 through 2023. We won the extra years back.

The second number in the release is the one that should follow you around. Healthy life expectancy — the years lived in full health — reached only 62.8 years in 2023, still 0.4 years below its 2019 level. Subtract one from the other and you get the gap the whole report quietly revolves around: ten and a half years. That is the average stretch of a human life now spent living with illness or disability. More than a decade per person, on average, lived unwell inside a lifespan that keeps lengthening.

"Living longer is one of the great achievements of public health," said Dr Alain Labrique, Director of WHO's Department of Data, Digital Health, Analytics and AI. "The next challenge is to ensure that those additional years are lived in good health, while health systems are equipped to respond to the changing needs of populations."

Chronic disease now owns the table

Underneath the lifespan figures, the cause-of-death table has been rebuilt. Noncommunicable diseases — cardiovascular conditions, cancer, diabetes, dementia and their kin — accounted for 74% of all deaths globally in 2023. In 2000, the figure was 58%. Of the world's ten leading causes of death in 2023, eight were noncommunicable. The killers of this century are, for the most part, not infections caught in a bad week. They are conditions acquired slowly and managed, or mismanaged, across decades.

The transition has now reached every income level. 2023 brought a first: in low-income countries, communicable diseases accounted for less than half of all deaths. Read that milestone both ways, because it cuts both. It records real victories against infectious killers, the product of vaccination, sanitation and treatment programmes that worked. And it lands health systems built around acute infections and maternal care with a completely different caseload: complex, lifelong conditions needing uninterrupted medication, routine monitoring and years of follow-up. Different diseases. Different plumbing entirely.

Consider what the 74% figure does to the design of a health system. A system built for communicable disease is built for episodes: diagnose, treat, discharge, count. A system in which three-quarters of deaths come from noncommunicable conditions has to be built for duration — for the patient whose diabetes, heart disease and arthritis arrive together and stay for thirty years. The low-income milestone is therefore not just an epidemiological curiosity. It is the moment the design problem of rich-country medicine became every country's problem.

Cardiovascular disease remains the single largest burden in the table. Ischaemic heart disease alone caused approximately 9.5 million deaths in 2023 and 210 million disability-adjusted life years — years of healthy life lost to early death and disability combined. There has been substantial progress against it in many parts of the world since 2000. But individual cardiovascular risk rose in the WHO Western Pacific and South-East Asia regions, a reminder that the global average conceals diverging local stories: improvement on one continent, deterioration on another, smoothed into a single reassuring line.

Dementia, diabetes, and the mind's growing share

Some figures in the release deserve a second read. Deaths from dementia, globally, tripled across the 2000–2023 span. Alzheimer's disease and other dementias became the fifth leading cause of death globally in 2023; in 2000, they ranked 19th. A climb from nineteenth to fifth in one generation is not drift. It is a reordering of what ends human lives — and it explains why the prevention evidence, including the modifiable-risk-factor evidence in OmniWire's account of cognitive longevity and the habits that delay neurodegeneration, keeps drawing attention well beyond neurology.

Dementia also stretches the healthspan problem across families, not just patients. A condition that tripled its global death count in twenty-three years is one that arrives with years of care attached — care delivered overwhelmingly outside hospitals, by households. Every year added to lifespan without a corresponding year of health is, for dementia above all, a year of somebody's labour. The gap is measured in DALYs. It is lived in kitchens.

Diabetes is moving in the same direction. The risk of dying from diabetes has risen substantially since 2000, particularly in South-East Asia, where rapid urbanisation and sedentary work are reshaping risk among working-age adults. These are not diseases of extreme old age arriving at the end of a healthy life. Increasingly, they arrive in the middle of one — in the working years, alongside the jobs and the mortgages — which is why the research world keeps circling back to metabolic basics, and to the screening numbers every adult is told to know and most don't.

Between 2019 and 2023, the global age-standardised DALY rate rose by approximately 20% for depressive disorders. For anxiety disorders, it jumped nearly 45%. Between them, the two conditions cost an estimated 110 million years of healthy life in 2023 alone. Let that figure settle: 110 million years of healthy life surrendered not to a virus or a tumour but to two conditions that most health systems still treat as somebody else's department.

Hold the mental-health figures against the headline gap and the ten and a half years look different. The gap between lifespan and healthspan is often imagined as physical frailty at the end of life. The DALY data say a large share of it is psychological, and much of it lands in mid-life.

Drug use disorders, by contrast, show a split map. Between 2000 and 2023, the WHO Region of the Americas recorded the largest increases in the risk of mortality and healthy life loss, while the Western Pacific saw substantial declines. Same decades, opposite directions. Policy and environment, the estimates suggest, are doing a great deal of that work. These curves are not weather. They bend where decisions bend them.

The mental-health burden lands on systems that still mostly treat mind and body in separate buildings, with separate budgets and separate waiting lists. Anyone who has read OmniWire's reporting on mindfulness-based stress reduction and chronic anxiety will recognise the mismatch: the burden is integrated, the care often isn't. A patient with diabetes and depression is one patient. The system frequently insists on treating two.

The causes are known, and mostly unglamorous

The WHO's framing keeps returning to a short list of drivers: tobacco use, physical inactivity, harmful alcohol intake, nutrient-poor diets and air pollution. Nothing on that list awaits a breakthrough drug. The recommended counters are equally familiar — at least 150 minutes of moderate aerobic activity a week, routine screening of blood pressure, blood glucose and lipids, diets built on vegetables, legumes, whole grains and lean proteins, and no tobacco. The gap between knowing and doing is where the DALYs live, which is why the conversation in OmniWire's look at the quiet shift around Zone 2 cardio and cardiovascular benchmarks keeps gaining an audience: people are looking for the minimum effective dose of the unglamorous stuff.

But the WHO is careful to aim beyond individual willpower. A person's ability to exercise, eat well and reach a clinic depends on income, urban design, food supply and air quality. Dr Rüdiger Krech, WHO's Director of Health Promotion, put the environmental piece bluntly in a 2026 statement on noncommunicable disease prevention: "Clean air is not negotiable; it is a foundation for dignity and life." Primary care built for the last century's problems — episodic, infectious, fix-and-discharge — has to become longitudinal: the same patient, the same team, the same numbers, tracked for decades. That is an organisational rebuild, not a poster campaign, and it competes for budgets with the acute care that can never be switched off.

A word of care about the data itself, before the conclusions harden. The Global Health Estimates synthesise national vital-registration systems, health surveys, disease surveillance and academic modelling. In several low- and middle-income countries, vital statistics remain incomplete or delayed, and modelling fills the gaps — which introduces a margin of uncertainty. The 2000–2023 series also uses updated methods, so it shouldn't be lined up naively against older WHO releases to manufacture a trend. The estimates exist so a health ministry can see its own curve bending and set priorities against evidence rather than habit.

None of that dulls the central finding. "The value of these estimates is not only in the numbers themselves," Dr Labrique said. "By showing how causes of death and disease burden are changing over time and across populations, they give countries evidence to help shape health policies and priorities."

So here is where global health actually stands in 2026. The pandemic's hit to lifespan has essentially been repaired. The slower, larger story — chronic disease, dementia, diabetes, depression — has only accelerated. Adding years to life turned out to be the tractable problem. Adding health to those years is the one now waiting, and on the WHO's own numbers, it is ten and a half years wide.

The estimates also quietly rebalance the credit for the recovery itself. Life expectancy returning to 73.3 years was not produced by a single intervention; it is the residue of a century of systems — sanitation, vaccination, maternal care, antibiotics — still compounding after a pandemic shock. The healthspan gap, by the same logic, will not close because of a single programme either. It will close, if it closes, when the systems built for the old disease table are rebuilt for the new one: primary care that follows the same patient across decades, screening that catches blood pressure and blood glucose while they are still numbers rather than diagnoses, cities where the 150 minutes of weekly activity the WHO recommends are physically possible, and mental-health care that shares a building and a budget with the rest of medicine.

Not every health threat is about ageing. In Sindh, rabies cases in two children showed how much depends on treatment in the first 15 minutes.

Extra years arriving in poor health is the gap longevity science is now organised around. Some of the attack is high-technology — the Nobel-recognised optogenetics work that turned an algae protein into a light switch for the brain opened a field still finding its clinical uses. The rest is unglamorous and testable: time-restricted feeding, NAD+ precursors and autophagy dynamics are being measured against the same healthspan question.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for personal medical decisions.